PA8472001A1 - Preparados efervescentes - Google Patents

Preparados efervescentes

Info

Publication number
PA8472001A1
PA8472001A1 PA19998472001A PA8472001A PA8472001A1 PA 8472001 A1 PA8472001 A1 PA 8472001A1 PA 19998472001 A PA19998472001 A PA 19998472001A PA 8472001 A PA8472001 A PA 8472001A PA 8472001 A1 PA8472001 A1 PA 8472001A1
Authority
PA
Panama
Prior art keywords
sugar
effervescent preparations
effervescent
preparations
alcohol
Prior art date
Application number
PA19998472001A
Other languages
English (en)
Inventor
Reinhard Walter
Petra Ohage
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of PA8472001A1 publication Critical patent/PA8472001A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

PREPARADOS EFERVESCENTES QUE CONTIENEN MEDICAMENTOS SON ESPECIALMENTE ESTABLES AL ALMACENAMIENTO SI CONTIENEN AZUCAR Y/O AZUCAR-ALCOHOL Y/O SUCEDANEO DE AZUCAR FUNDIBLES.
PA19998472001A 1998-05-15 1999-05-06 Preparados efervescentes PA8472001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19822036A DE19822036A1 (de) 1998-05-15 1998-05-15 Brausezubereitungen

Publications (1)

Publication Number Publication Date
PA8472001A1 true PA8472001A1 (es) 2000-09-29

Family

ID=7868010

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19998472001A PA8472001A1 (es) 1998-05-15 1999-05-06 Preparados efervescentes

Country Status (30)

Country Link
EP (1) EP1077684B1 (es)
JP (1) JP4452403B2 (es)
KR (1) KR100629817B1 (es)
AR (1) AR016473A1 (es)
AT (1) ATE246494T1 (es)
AU (1) AU3929799A (es)
BR (1) BR9910454A (es)
CA (1) CA2331671C (es)
CO (1) CO4830457A1 (es)
CZ (1) CZ300778B6 (es)
DE (2) DE19822036A1 (es)
DK (1) DK1077684T3 (es)
EE (1) EE04701B1 (es)
ES (1) ES2203134T3 (es)
GT (1) GT199900062A (es)
HN (1) HN1999000067A (es)
HR (1) HRP20000781B1 (es)
HU (1) HU224034B1 (es)
ID (1) ID27441A (es)
IL (1) IL139240A (es)
NO (1) NO20005722L (es)
PA (1) PA8472001A1 (es)
PE (1) PE20000465A1 (es)
PL (1) PL194347B1 (es)
PT (1) PT1077684E (es)
SI (1) SI1077684T1 (es)
SK (1) SK284621B6 (es)
TR (1) TR200003357T2 (es)
UY (1) UY25510A1 (es)
WO (1) WO1999059553A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
EP1150660B1 (de) * 1999-02-11 2004-01-21 Hexal Ag Pharmazeutische, metamizol enthaltende brauseformulierung
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
WO2006082499A1 (en) * 2005-02-03 2006-08-10 Nycomed Pharma As Melt granulation of a composition containing a calcium-containing compound
GR1007299B (el) * 2010-03-24 2011-06-06 Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε, Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
EP3193843A1 (en) 2014-09-17 2017-07-26 Steerlife India Private Limited Effervescent composition and method of making it
US11559483B2 (en) * 2015-07-10 2023-01-24 Sanjay Gupta Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene
WO2017098481A1 (en) * 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
JP2018183067A (ja) * 2017-04-24 2018-11-22 株式会社松原製餡所 発泡性添加物、及び、餡食品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004036A (en) * 1966-05-31 1977-01-18 Alberto Culver Company Effervescent molded triturate tablets
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
DE69102900T3 (de) * 1990-02-14 1998-04-09 Otsuka Pharma Co Ltd Brausemischung, deren Herstellung sowie Verwendung.
RU2096955C1 (ru) * 1991-03-01 1997-11-27 Е.И.Дюпон Де Немур Энд Компани Вододиспергируемая гранулированная пестицидная композиция, получаемая методом экструзии, и способ ее получения
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
AU677432B2 (en) * 1993-09-09 1997-04-24 Gerhard Gergely Effervescent granulated material and method for its preparation
GB2307857B (en) * 1995-12-04 1999-01-27 Euro Celtique Sa An effervescent formulation

Also Published As

Publication number Publication date
AR016473A1 (es) 2001-07-04
CZ20004171A3 (cs) 2001-03-14
DE59906519D1 (de) 2003-09-11
EP1077684B1 (de) 2003-08-06
ID27441A (id) 2001-04-12
HUP0101822A2 (hu) 2002-03-28
SI1077684T1 (en) 2003-12-31
HN1999000067A (es) 1999-09-29
BR9910454A (pt) 2001-01-02
JP2002515422A (ja) 2002-05-28
UY25510A1 (es) 1999-12-13
PE20000465A1 (es) 2000-07-07
SK17062000A3 (sk) 2001-04-09
AU3929799A (en) 1999-12-06
KR20010043600A (ko) 2001-05-25
PT1077684E (pt) 2003-12-31
GT199900062A (es) 2000-10-20
EP1077684A1 (de) 2001-02-28
NO20005722D0 (no) 2000-11-13
JP4452403B2 (ja) 2010-04-21
NO20005722L (no) 2001-01-15
CA2331671A1 (en) 1999-11-25
CZ300778B6 (cs) 2009-08-12
HUP0101822A3 (en) 2002-12-28
IL139240A (en) 2005-08-31
DE19822036A1 (de) 1999-11-18
ES2203134T3 (es) 2004-04-01
HU224034B1 (hu) 2005-05-30
SK284621B6 (sk) 2005-07-01
PL344140A1 (en) 2001-10-08
EE04701B1 (et) 2006-10-16
CA2331671C (en) 2008-01-08
EE200000650A (et) 2002-04-15
CO4830457A1 (es) 1999-08-30
PL194347B1 (pl) 2007-05-31
TR200003357T2 (tr) 2001-05-21
DK1077684T3 (da) 2003-11-17
HRP20000781A2 (en) 2001-06-30
HRP20000781B1 (en) 2010-06-30
WO1999059553A1 (de) 1999-11-25
KR100629817B1 (ko) 2006-09-29
IL139240A0 (en) 2001-11-25
ATE246494T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
DK0686122T3 (da) Lukke til medicinsk beholder.
NO902670D0 (no) Dobbel kosmetikk-applikator og beholder.
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
FI973051A (fi) Steriloimis- ja säilytyskotelo kirurgisia instrumentteja varten
FR2696338B1 (fr) Ligament artificiel et son mode de presentation.
PA8472001A1 (es) Preparados efervescentes
DE69633145D1 (de) Lager-, anzeige- und konservierungsverpackung
KR970000234A (ko) 디하이드로에보디아민-hc1를 유효성분으로 함유하는 기억항진 및 치매 치료제
BR9709406B1 (pt) fluorenonas alquiloxiamino substituìdas e composição farmacêutica contendo as mesmas.
BR9710221A (pt) Recipiente acondicionador de configuração estável e uso do mesmo
NO900744L (no) Tennsystem og selv-oppvarmende beholder.
DE68913060D1 (de) Aufbewahrungs- und Ausgabesystem.
AU585818B2 (en) Display case for fragrance bottles, jewelry or the like, and hinge use therein
EP0967222A4 (en) CYCLIC DEPSIPEPTIDES AND MEDICINES CONTAINING THESE COMPOUNDS AS ACTIVE INGREDIENT
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b
ECSP992952A (es) Preparados efervescentes (caso lea 32842)
BR9611619B1 (pt) ciclopeptolìdeos e composição farmacêutica que os contêm.
UY28032A1 (es) Preparados efervescentes
IT242042Y1 (it) Contenitore in ovatta sterile.
IT9048026A0 (it) Preparato farmaceutico e/o cosmetico.
ES1037335Y (es) Mejoras introducidas en la presentacion de periodicos y publicaciones similares.
BR7500105U (pt) Disposição introduzida em estante
IL117304A0 (en) Fsf-1 fibrosin and pharmaceutical compostions containing the same
ITMI910075V0 (it) Apparecchio vaporizzatore di sostanze insetticide, in particolare cont
IT241431Y1 (it) Flacone e/o involucro biuso